These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 26025306)
1. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis. Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306 [TBL] [Abstract][Full Text] [Related]
2. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Yamamoto T; Kuroda M; Nishioka K Arch Dermatol Res; 2000 Nov; 292(11):535-41. PubMed ID: 11194891 [TBL] [Abstract][Full Text] [Related]
3. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis. Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703 [TBL] [Abstract][Full Text] [Related]
5. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940 [TBL] [Abstract][Full Text] [Related]
6. Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skin. Böhm M; Stegemann A Exp Dermatol; 2014 Jun; 23(6):431-3. PubMed ID: 24698097 [TBL] [Abstract][Full Text] [Related]
7. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342 [TBL] [Abstract][Full Text] [Related]
8. Scleroderma-like Impairment in the Network of Telocytes/CD34 Rosa I; Romano E; Fioretto BS; Guasti D; Ibba-Manneschi L; Matucci-Cerinic M; Manetti M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830288 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523 [TBL] [Abstract][Full Text] [Related]
10. Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis. Reich N; Tomcik M; Zerr P; Lang V; Dees C; Avouac J; Palumbo K; Horn A; Akhmetshina A; Beyer C; Xie W; Bennett BL; Distler O; Schett G; Distler JH Ann Rheum Dis; 2012 May; 71(5):737-45. PubMed ID: 22258492 [TBL] [Abstract][Full Text] [Related]
11. 17,20S(OH) Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632 [TBL] [Abstract][Full Text] [Related]
12. The Antifibrotic Effect of A Karmouty-Quintana H; Molina JG; Philip K; Bellocchi C; Gudenkauf B; Wu M; Chen NY; Collum SD; Ko J; Agarwal SK; Assassi S; Zhong H; Blackburn MR; Weng T Arthritis Rheumatol; 2018 Oct; 70(10):1673-1684. PubMed ID: 29771006 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Matsushita M; Yamamoto T; Nishioka K Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778 [TBL] [Abstract][Full Text] [Related]
14. Peripheral Hybrid CB Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521 [TBL] [Abstract][Full Text] [Related]
15. A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel. Jun JB; Kim JK; Na YI; Jang SM; Paik SS; Kim YH Rheumatol Int; 2012 May; 32(5):1443-7. PubMed ID: 21448642 [TBL] [Abstract][Full Text] [Related]
17. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
18. Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma. Jiang M; Yu Y; Luo J; Gao Q; Zhang L; Wang Q; Zhao J J Invest Dermatol; 2017 Jun; 137(6):1223-1233. PubMed ID: 28132855 [TBL] [Abstract][Full Text] [Related]
19. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice. Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains. Oi M; Yamamoto T; Nishioka K J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]